We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Planet Fitness
PLNT
$3.78B
| $45M | 0.1% |
1,190,460
+579,375
| +95% | +$20.3M |
|
202
Ametek
AME
$58.2B
| $44.5M | 0.1% |
586,271
+394,017
| +205% | +$29.9M |
|
203
Cboe Global Markets
CBOE
$29.9B
| $44M | 0.1% |
385,417
+148,650
| +63% | +$18.1M |
|
204
Regions Financial
RF
$26.8B
| $43.8M | 0.1% |
2,358,700
+2,198,100
| +1,369% | +$41.6M |
|
205
Accenture
ACN
$108B
| $43.7M | 0.1% |
+284,769
| New | +$45.1M |
|
206
Children's Place
PLCE
$59.8M
| $43.7M | 0.1% |
323,031
+220,923
| +216% | +$32.1M |
|
|
CLGX
207
DELISTED
Corelogic, Inc.
CLGX
| $43.1M | 0.1% |
952,923
+323,699
| +51% | +$14.9M |
|
208
Brown & Brown
BRO
$23.9B
| $42.9M | 0.1% |
1,687,480
+993,140
| +143% | +$25.9M |
|
209
PetMed Express
PETS
$42.3M
| $42.3M | 0.1% |
1,013,534
| – | – |
|
210
Ares Capital
ARCC
$14.4B
| $41.1M | 0.09% |
2,592,206
-2,008,447
| -44% | -$31.8M |
|
211
iShares MSCI Taiwan ETF
EWT
$10.7B
| $41.1M | 0.09% |
1,072,734
-3,860,393
| -78% | -$146M |
|
212
Grupo Cibest SA
CIB
$21.1B
| $41.1M | 0.09% |
976,943
+423,395
| +76% | +$18.4M |
|
213
CBRE Group
CBRE
$42.9B
| $40.7M | 0.09% |
862,343
+274,243
| +47% | +$12.5M |
|
214
Philips
PHG
$26.1B
| $40.1M | 0.09% |
1,379,791
-4,367,352
| -76% | -$130M |
|
215
Encompass Health
EHC
$12.4B
| $40.1M | 0.09% |
881,945
+701,697
| +389% | +$30.1M |
|
216
Northern Trust
NTRS
$33.9B
| $40.1M | 0.09% |
388,850
-307,556
| -44% | -$32.2M |
|
217
SolarEdge
SEDG
$1.95B
| $40M | 0.09% |
760,874
+90,193
| +13% | +$3.95M |
|
|
IRBT
218
DELISTED
iRobot
IRBT
| $39.3M | 0.09% |
612,486
-365,842
| -37% | -$27.5M |
|
219
H&R Block
HRB
$5.86B
| $38.7M | 0.09% |
1,522,542
+1,123,700
| +282% | +$29.6M |
|
220
National Beverage
FIZZ
$3.01B
| $38.6M | 0.09% |
867,380
-67,404
| -7% | -$3.32M |
|
221
NRG Energy
NRG
$24.8B
| $37.7M | 0.09% |
1,234,000
+889,415
| +258% | +$24.6M |
|
222
Church & Dwight Co
CHD
$24.5B
| $37.6M | 0.09% |
747,100
+416,600
| +126% | +$20.5M |
|
223
EPAM Systems
EPAM
$5.03B
| $36.9M | 0.08% |
322,227
+302,579
| +1,540% | +$34.6M |
|
224
Herbalife
HLF
$1.29B
| $36.4M | 0.08% |
746,414
+153,998
| +26% | +$6.54M |
|
225
Illumina
ILMN
$28.4B
| $36.1M | 0.08% |
157,109
-107,087
| -41% | -$24.5M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.